Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gore Range Capital
New York, New York, United Statesgorerangecapital.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Gore Range Capital is an active healthcare venture capital firm focused on early-stage investments in skin health businesses, including innovations in dermatology, diagnostics, aesthetics, and medical devices. Its portfolio includes companies developing diagnostics for ovarian cancer, treatments for hair loss, targeted fat reduction, and more, with select companies at clinical and commercial stages[1][2][3].
- Therapeutic areas
- OncologyWomen's HealthDermatology
- Modalities
- Small moleculeMonoclonal antibodyRNA therapyBiologicDevice
- Industry
- Investors
02
Partnerships
Sirnaomics (creation of Sagesse Bio for RNAi therapeutics)Or-Genix (LATAM Dermatology Markets partnership)
Beyond the preview
Go deeper on Gore Range Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gore Range Capital.